The existence of a five-membered isozyme system for human phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) has been demonstrated. These multimolecular forms result from the random polymerization of two distinct subunits, M (muscle type) and L (liver type), to form all possible tetrameters-i.e., M4 
were hybridized by dissociation at low pH and then recombination at neutrality. Three hybrid species were generated in addition to the two parental isozymes, to yield an entire fivemembered set. The various species could be consistently and reproducibly separated from one another by DEAE-Sephadex chromatography at pH 8.0 with a concave elution gradient of salt. Under similar experimental conditions, erythrocyte PFK from hemolysates was also resolved into five species chromatographiclly indistinguishable from those produced in the above experiment. Immunological and kinetic studies of the isozymes provided corroborative evidence to support the proposed subunit structures. Erythrocyte PFK was found to have kinetic properties intermediate between those of muscle and liver PFK and was neutralized only 50% by an antiserum against muscle PFK that completely neutralized muscle PFK. These data demonstrate that muscle and liver PFKs are distinct homotetramers-i.e., M4 and L4, respectively-whereas erythrocyte PFK is a heterogeneous mixture of all five isozymes. The structural heterogeneity of erythrocyte PFK provides a molecular genetic basis for the differential organ involvement observed in some inherited PFK deficiency states in which myopathy or hemolysis or both can occur.
Like most allosteric enzymes, phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11), a key enzyme of glycolysis, is a multimeric protein, the smallest active oligomer being a tetramer. The enzyme from a large number of plant, bacterial, nonvertebxate, and vertebrate species has been purified and studied. The physicochemical and kinetic properties of PFKs from various mammalian tissues have been investigated, and in a few instances, multimolecular forms have been noted (1) . At least four forms of PFK have been reported in tumors and normal tissues of rats on the basis of ion-exchange chromatography elution profiles and of antibody precipitation tests (2, 3) . The extensive studies by have demonstrated the presence of a multilocus isozyme system for PFK in the rabbit. In this species, three separate genetic loci code for a structurally different polypeptide subunit of PFK; either one or two of these polypeptides are expressed in each tissue, resulting in the formation of either single (homotetrarneric) or multiple (homo-and heterotetramertic) isozymes.
The existence of an isozyme system for PFK in man was first suggested in 1965 by the observation of a recessively inherited muscle disease associated with PFK deficiency in three siblings of a Japanese family (8) . In these individuals, PFK activity was entirely absent in muscle and was half normal in erythrocytes.
The clinical effects of the enzymatic defect consisted of generalized muscle weakness and compensated hemolysis. The differential tissue involvement led to the hypothesis that the erythrocyte isozyme is composed of two types of subunits, one of which is the sole subunit present in muscle PFK (9, 10) . The proposed structural heterogeneity of erythrocyte PFK protein was supported by immunochemical neutralization experiments (11, 12) . Karadsheh et al. (13) and Kaur and Layzer (14) have recently presented data to support the suggested hybrid structure for erythrocyte PFK. The present study addressed the following three basic questions: (i) Could erythrocyte PFK be a mixture of all five theoretically possible tetramers composed of two distinct subunits, rather than a single hybrid species? (ii) What is the tissue of origin of the nonmuscle subunit identified as an "E" or "R" subunit (13, 14) by other workers? (ii) What are the relative proportions of these two subunits in the erythrocytes?
Preliminary results of these studies have been presented (15) .
MATERIALS AND METHODS Chemicals and Reagents. Adenosine nucleotides, NAD, NADH, Fru-6-P, Fru-1,-P2, dithiothreitol, glycylglycine, and sodium glycerophosphate were purchased from Sigma; auxiliary enzymes were from Boehringer Mannheim; Freund's complete and incomplete adjuvants were from Difco; DEAEcellulose (DE-52) was from Whatman; DEAE-Sephadex A-25 was from Pharmacia; agarose-hexane-ATP (AGATP), type was kept constant (0.1 mM) and Fru-6-P concentration was varied from 0.025 to 1.6 mM. Vnx was measured by activation with 0.2 mM AMP. The KO.5 Fru-6-P value for each isozyme was calculated from the Hill plots.
Preparation of PFKs from Muscle, Liver, and Erythrocytes. Muscle PFK was partially purified according to the method of Kemp (16) except that the crystallization steps were omitted. For the immunization of rabbits, this preparation was subjected to DEAE-cellulose chromatography (17) followed by affinity chromatography (18) . The final preparation yielded a single band on sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Protein determination was according to Lowry et al. (19) . Partial purification of liver PFK was carried out according to the method of Brock (20) , and that of erythrocyte PFK was according to the procedure described by Wenzel et al. (21) except that, in both cases, the final gel filtration steps were omitted.
Chromatographic Separation of PFK Isozymes. All the operations were carried out at 4VC. The columns were loaded with 0.1-0. 15 unit of the enzyme preparation. For linear gradient elution, a DEAE-Sephadex A-25 column (1.7 X 30 cm) was equilibrated in 0.1 M Tris phosphate, pH 8.0/0.2 mM EDTA/0.2 mM AMP/0.7 mM dithiothreitol. A 100-ml linear gradient of NaCl from 0 to 0.8 M prepared in the equilibrating buffer was used for elution; 100 fractions were collected. For concave gradient elution, the gel was equilibrated in the buffer mentioned above, to which 0.025 M NaCI was added. Elution was done with a 300-ml concave gradient of NaCI from 0.025 to 0.525 M in the same buffer; 100 fractions were collected. Dissociation and Reassociation Experiments with PFKs from Muscle and Liver. These were performed according to the procedure described by Tsai and Kemp (4) (Fig. 1A) . This technique, however, could not resolve muscle and erythrocyte PFKs distinctly from each other. Under identical experimental conditions, erythrocyte PFK was resolved into a broad major fraction with its peak in a position just overlapping the right descending limb of muscle PFK and a minor fraction with its peak in the position of the liver isozyme (Fig. 1C) .
Muscle and liver preparations were recovered quantitatively (90 + 10%) when either crude tissue homogenates or partially purified preparations were chromatographed. Crude erythrocyte hemolysates yielded quantitative recovery but partially purified ones did not. The poor recoveries (approximately 30%) of the latter may be explained by the tendency of human erythrocyte PFK to undergo self-aggregation to high molecular weight species, with a concomitant decline in specific activity, at high protein concentrations (22) .
Chromatographic Separation of Native PFKs on Concave Elution Gradients. The broad major peak of erythrocyte PFK was resolved into four peaks when the early phase of the linear eluting gradient was expanded by using a concave gradient (Fig. 1D) . The first and last peaks eluted in the same positions as muscle and liver isozymes, respectively (Fig. 1B) .
The muscle-and liver-type species of native erythrocyte PFK could be quantitated with some degree of accuracy and were found to comprise 1% and 6-11%, respectively, of the total enzyme. However, the hybrids could not be quantitated, due to the overlap of their peaks. (Fig. 2B) (23) . Control of glycolysis is usually explained in terms of the allosteric properties of three enzymes: PFK, hexokinase, and pyruvate kinase. Generally, the PFK step is considered to be the major rate-limiting reaction (24, 25 (27) (28) (29) (30) (31) (32) . The hypothesis of a common muscle-type subunit in both muscle and erythrocyte PFKs was initially suggested by immunochemical neutralization studies (11, 12) . Muscle and erythrocyte enzymes were also shown to be separable by DEAE-cellulose chromatography and a stepwise elution gradient of salt (12) . Recent studies have shown that human erythrocyte PFK is composed of two nonidentical subunits, of 85,000 and 80,000 daltons, respectively. The 85,000-dalton subunit is designated "muscle type" because it is found to be identical to the sole subunit present in muscle PFK on the basis of their tryptic peptide maps (13) . The 80,000-dalton subunit is assumed to be specific for erythrocytes and is designated as "E (erythrocyte)" or "R (red cell)" subunit. The relative proportions of these two have been variably reported to be 1:2.9 (13) and 1.2 or less (14) . However, none of these studies identified the nature of the nonmuscle subunit or addressed the question of why only a single heterotetrameric molecule would be assembled in erythrocytes, rather than the entire five-membered set, if two distinct subunits were present.
Our data demonstrate that the nonmuscle subunit of eryth- We initially chose to determine whether human skeletal muscle and liver PFKs were truly distinct homotetrameric isozymes or not, as they are in the case of the rabbit (4, 33, 34) .
Although indistinguishable by electrophoresis, these two were readily resolved by DEAE-Sephadex chromatography. The resolution of erythrocyte PFK into two peaks suggested that the minor peak may be similar to the liver isozyme and the major one may consist of either one or many hybrid isozymes, composed of both muscle and liver type subunits.
When the broad peak of erythrocyte PFK was further resolved by using a concave gradient, it separated into four peaks. (33) . Dissociation and reassociation of human muscle and liver PFKs yielded three additional hybrid species, as well as the original homotetramers. In the control experiment, when muscle and liver PFKs were mixed after independent dissociation and reassociation, the two original homotetramers were obtained, along with a small peak in the ML3 position. This ML3 peak was due to muscle subunits contaminating the liver preparation.
These results were consistent with the concept that muscle and liver PFKs are different proteins with homotetrameric structures.
The random recombination of equal numbers of two distinct subunits (M and L) is expected to yield five isozymes in a 1:4:
Biochemistry: Vora et al. 6 :4:1 ratio, as predicted by the binomial distribution, provided that both subunits exhibit similar intra-and interspecies affinities in vitro. The deviation from a binomial distribution of five peaks in our study reflects the excessive loss of M subunits during low pH treatment. In fact, during hybridization, the M:L ratio was increased to 1.5:1, and a symmetrical distribution was evident. A further excess of M or L subunits yielded isozyme profiles that were highly skewed toward M-or L-containing species, respectively. These data indicated that in vitro, interspecies and intraspecies affinities of each subunit were equal.
Partially purified erythrocyte PFK, after dissociation and reassociation, yielded an isozymic profile nearly identical to that produced by muscle and liver PFKs hybridized in equal proportions. This finding suggested that, in native erythrocyte PFK, the ratio of M to L subunits cannot be very different from unity. This conclusion is also supported by the clinical observation that patients genetically lacking M subunits exhibit half-normal levels of erythrocyte PFK (8, 9, 36) .
Our immunological and kinetic studies provide further support to the proposed subunit structures of PFK isozymes. An excess of anti-human muscle PFK serum precipitated >90% of muscle PFK and approximately 50% of erythrocyte PFK, as shown by other investigators (11, 12) . However, our experiments indicated that this antiserum failed to precipitate liver enzyme. In Ouchterlony analysis, muscle and liver PFK each yielded a single precipitin line which showed a reaction of identity, but liver PFK failed to react. The absence of crossreactivity between muscle and liver PFK suggested the presence of large structural differences between M and L subunits. This is in agreement with the reported differences in the tryptic peptide maps and amino acid compositions between the two subunits of erythrocyte PFK (13) and supports our hypothesis that the nonmuscle subunit of erythrocyte PFK is similar to the liver isozyme. The erythrocyte isozymes as a group exhibited a K0.5 Fru-6-P value (in the presence or absence of AMP) intermediate between those of muscle and liver PFKs.
From the evidence presented, we conclude that human muscle and liver PFKs are distinct homotetramers-i.e., M4 and L4-distinguishable by their physicochemical, kinetic, and immunological properties; erythrocyte PFK, until now considered a single hybrid isozyme, is a mixture of two homotetramers and three hybrid isozymes. Our studies are consistent with the existence of two structural loci coding for M and L subunits, which give rise to a five-membered isozyme system. In accordance with the recommendation of the International Union of Biochemistry Enzyme Commission (37), we propose that liver isozyme be referred to as PFK-1, the muscle isozyme as PFK-5, and the hybrids as PFK-2, -3, and -4.
The genetic heterogeneity of erythrocyte PFK may explain the reduction in the erythrocyte enzyme activity by approximately 50% observed in inherited PFK deficiency associated with myopathy. If this syndrome is due to complete lack of the muscle-type PFK, the residual erythrocyte enzyme is expected to be liver-type. We have recently demonstrated the exclusive presence of the liver-type isozyme in the erythrocytes of such an individual (36) . It can be speculated that the heterogeneous group of hemolytic syndromes associated with partial erythrocyte PFK deficiency without myopathy (38) (39) (40) (41) may be secondary to the total absence of L subunits or qualitative defects of M or L subunits.
